Wacker Biotech US Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Wacker Biotech US Inc. - overview
Established
2018
Location
San Diego, CA, US
Primary Industry
Biotechnology
About
Founded in 2018 and based in San Diego, US, Wacker Biotech US Inc. , formerly known as Genopis Inc. , operates as a biopharmaceutical company that offers contract development and manufacturing services for drugs and various treatments. In June 2020, Genopis Inc.
raised Series B funding from investor Medivate Partners. Later In February 2021, Wacker Chemie agreed to acquire a full ownership stake in Genopis Inc. for USD 42 million. The company offers a range of services, including molecular biology, process development, analytical development, and GMP manufacturing of biologics.
The company engages in the biologics industry, providing services for the development and manufacturing of biopharmaceutical products and solutions for various sectors like pharmaceuticals and food additives.
Current Investors
LINEA Investment, Helixmith
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development, Biomaterials
Website
www.wacker.com/biologics
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Wacker Biotech US Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Joint Venture | Completed | Wacker Biotech US Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.